Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Signal Genetics Cmn (SGNL)

Signal Genetics Cmn (SGNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Signal Genetics Cmn 5740 FLEET STREET CARLSBAD CA 92008 USA

www.signalgenetics.com P: 760-537-4100

Description:

Signal Genetics, Inc. is an emerging commercial stage, molecular diagnostic company. It is focused on providing diagnostic services that help physicians in decision making for the care of cancer patients. The Company's flagship diagnostic service is the Myeloma Prognostic Risk Signature, or MyPRS (TM). Signal Genetics, Inc. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 9,102
Shares Outstanding, K 740
Annual Sales, $ 2,540 K
Annual Net Income, $ -11,330 K
Last Quarter Sales, $ 890 K
Last Quarter Net Income, $ -1,840 K
60-Month Beta 1.48
% of Insider Shareholders 26.40%
% of Institutional Shareholders 84.60%

Growth:

1-Year Return 74.47%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/15/17
Earnings Per Share ttm -11.55
EPS Growth vs. Prev Qtr 11.54%
EPS Growth vs. Prev Year 30.30%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/07/16

SGNL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -135.01%
Return-on-Assets % -100.07%
Profit Margin % -446.06%
Debt/Equity N/A
Price/Sales 2.81
Price/Cash Flow N/A
Price/Book 1.89
Book Value/Share 6.51
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar